<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">78778</id>
  <title nil="true"/>
  <common-name>Acetamide, N-[5-[bis(2-butoxyethyl)amino]-2-[(5-nitro-2-thiazolyl)azo]phenyl]-</common-name>
  <description>Acetamide, N-[5-[bis(2-butoxyethyl)amino]-2-[(5-nitro-2-thiazolyl)azo]phenyl]- belongs to the anilides, a subclass of benzene and substituted derivatives within the organic compounds. It is classified as a benzenoid with the formula C23H34N6O5S1. With an average molecular weight of 506.62 g/mol, Acetamide, N-[5-[bis(2-butoxyethyl)amino]-2-[(5-nitro-2-thiazolyl)azo]phenyl]- is a heavy molecule.</description>
  <cas>72010-87-8</cas>
  <pubchem-id>172945</pubchem-id>
  <chemical-formula>C23H34N6O5S1</chemical-formula>
  <weight>506.6</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-04-04T13:01:11Z</created-at>
  <updated-at type="dateTime">2026-08-30T20:11:47Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CCCCOCCN(CCOCCCC)C1=CC(NC(C)=O)=C(C=C1)N=NC1=NC=C(S1)[N+]([O-])=O</moldb-smiles>
  <moldb-formula>C23H34N6O5S1</moldb-formula>
  <moldb-inchi>InChI=1S/C23H34N6O5S/c1-4-6-12-33-14-10-28(11-15-34-13-7-5-2)19-8-9-20(21(16-19)25-18(3)30)26-27-23-24-17-22(35-23)29(31)32/h8-9,16-17H,4-7,10-15H2,1-3H3,(H,25,30)/b27-26+</moldb-inchi>
  <moldb-inchikey>VGJJSEWJLPZTRY-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal">506.62</moldb-average-mass>
  <moldb-mono-mass type="decimal">506.231139</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>4.7</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id>151033</chemspider-id>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM074671</chemdb-id>
  <dsstox-id>DTXSID8072459</dsstox-id>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id>NS00037315</susdat-id>
  <iupac>N-[5-[bis(2-butoxyethyl)amino]-2-[(5-nitro-1,3-thiazol-2-yl)diazenyl]phenyl]acetamide</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Benzenoids</superklass>
  <klass>Benzene and substituted derivatives</klass>
  <subklass>Anilides</subklass>
  <paper-count type="integer">0</paper-count>
  <sync-id>CED0159478</sync-id>
  <structure-inchikey>VGJJSEWJLPZTRY-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>42000000000000000800000000002000000002800000000000000000004000002000002000000000000000000002000000000000002000000000000000000000000000000000000010020000000000020000010081100001204000000400000000020010000000200400000104000000000001000000480100000000000402000000040000100008000000000000280000000001000000080000000000000000000000204001000000000080000000000000010080000000001000000000100000000004000000000000000000000000003000000000000800200000000000000008000000000000040000000010400800001001000000080000000000000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAjAAAAJAAAAIABBgBgAAAAAQMGAGAAAAAC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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T04:26:10Z</structure-indexed-at>
</compound>
